Tobi Podhaler Capsule
Product Images NDC 49502-401

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Tobi Podhaler (NDC 49502-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Patient Information Leaflet Figure A (Image 01)

An instructional diagram illustrating the dosing schedule cycle for TOBI Podhaler capsules. It shows two phases: On TOBI Podhaler, instructing to take the capsule twice daily every day for 28 days, and Off TOBI Podhaler, advising to not take the capsule for the next 28 days, with arrows indicating the cycle repeats.*

FDA Label Image

Tobi Podhaler Carton (Image 02)

Packaging label for TOBI Podhaler, tobramycin inhalation powder capsules with a strength of 28 mg per capsule. The label features blue and white colors, the brand name prominently displayed, and usage information stating that the capsules are for oral inhalation only and used with the Podhaler device. The label also shows Mylan branding and indicates the package contains a 4-week supply of capsules (4 weekly packs x 56 capsules per pack).*

FDA Label Image

Tobramycin Structural Formula (Image 04)

Chemical structure of tobramycin, the active ingredient in TOBI Podhaler, shown as a molecular diagram with atoms and bonds.*

FDA Label Image

Figure 1 – Study 2: Mean Relative Change In Fev1 % Predicted From Baseline In Cycles 1 To 3 By Treatment Group (Image 05)

A line graph comparing the percentage predicted relative change from baseline in FEV1 over 25 weeks for TOBI Podhaler and placebo groups. The x-axis shows weeks, and the y-axis indicates percent change. Error bars represent 95% confidence intervals for the mean relative change.*

FDA Label Image

Instructions For Use Figure A (Image 08)

Illustration showing components of the TOBI Podhaler inhalation system, including a blister card containing capsules, a Podhaler device with capsule chamber, mouthpiece, and button, and a storage case with lid and base.*

FDA Label Image

Instructions For Use Figure B (Image 09)

An instructional illustration labeled Figure B showing a person washing their hands under a running faucet, with water flowing over the hands and soap bubbles visible on the skin.*

FDA Label Image

Instructions For Use Figure C (Image 10)

An instructional diagram showing components of the TOBI Podhaler device and storage case. It labels the storage case with lid and base, and the Podhaler device with capsule chamber, mouthpiece, and button for use with Tobramycin capsules.*

FDA Label Image

Instructions For Use Figure D (Image 11)

Illustration labeled 'Figure D' depicting a hand holding an inhalation device, likely demonstrating usage or assembly related to TOBI Podhaler capsules for respiratory administration.*

FDA Label Image

Instructions For Use Figure E (Image 12)

Illustration labeled Figure E showing a detailed diagram of a medication inhaler device tip or nozzle, likely related to the TOBI Podhaler inhalation capsules, depicting structural components needed for use.*

FDA Label Image

Instructions For Use Figure F (Image 13)

An instructional illustration showing a person holding a TOBI Podhaler inhalation device with one hand while using the other hand to manipulate the top portion, likely demonstrating device preparation or capsule insertion for inhalation of tobramycin capsules.*

FDA Label Image

Instructions For Use Figures G And H (Image 14)

Illustrations labeled Figure G and Figure H demonstrating the removal of capsules from a blister pack for TOBI Podhaler. Arrows indicate opening actions to access the capsules within the packaging, supporting proper use of the respiratory inhalation capsules.*

FDA Label Image

Instructions For Use Figure I (Image 15)

An instructional illustration showing the use of the TOBI Podhaler inhalation device loaded with a capsule. The capsule is placed into the device before inhalation, demonstrating the preparation step for administering TOBI Podhaler capsules (Tobramycin) via respiratory inhalation.*

FDA Label Image

Instructions For Use Figure J (Image 16)

An instructional diagram showing four sequential steps to open and prepare TOBI Podhaler capsules. Each frame depicts a hand turning and lifting a capsule blister to access individual capsules, illustrating proper capsule removal from packaging for inhalation use.*

FDA Label Image

Instructions For Use Figure K (Image 17)

Illustration labeled 'Figure K' showing a capsule inhaler device with an arrow pointing downward onto the capsule, indicating a step in the use or assembly of the TOBI Podhaler capsule for oral inhalation.*

FDA Label Image

Instructions For Use Figure L (Image 18)

An instructional diagram showing two views of a device component labeled Figure L. The illustration likely depicts parts of an inhalation device, highlighting the device's spray nozzle and cap assembly from different angles, demonstrating how to open or assemble the pieces.*

FDA Label Image

Instructions For Use Figure M (Image 19)

An instructional illustration depicting a hand holding and pressing down on a small capsule-like device, likely demonstrating the method to use the TOBI Podhaler capsule for inhalation administration.*

FDA Label Image

Instructions For Use Figure N (Image 20)

An instructional illustration showing a side profile of a person's face exhaling or breathing out, indicated by arrows pointing away from the mouth. This image likely demonstrates the respiratory action related to using the TOBI Podhaler oral inhalation capsules.*

FDA Label Image

Instructions For Use Figure O (Image 21)

An instructional illustration showing a person using an inhaler device by holding it to their mouth and inhaling. The image is labeled as Figure O and depicts the correct inhalation technique for a respiratory medication.*

FDA Label Image

Instructions For Use Figure P (Image 22)

An instructional illustration showing a person using the TOBI Podhaler capsule inhalation device. The image depicts the correct positioning of the inhaler mouthpiece in the mouth for oral respiratory administration of the medication.*

FDA Label Image

Instructions For Use Figures Q And R (Image 23)

Two-panel instructional illustration. Figure Q shows a device assembly step involving attaching or positioning a component on a inhaler-like device. Figure R depicts a hand with a capsule being dropped from a container or device, suggesting capsule handling or loading instructions for an inhalation product like TOBI Podhaler.*

FDA Label Image

Instructions For Use Figure S (Image 24)

An instructional diagram illustrating the correct method for emptying a TOBI Podhaler capsule. It shows a capsule with fine powder coating and piercing holes, indicating proper handling to release the medication.*

FDA Label Image

Instructions For Use Figure T (Image 25)

An instructional diagram illustrating a TOBI Podhaler capsule, showing powder inside and the capsule's piercing holes. It includes a caution note indicating the capsule is not emptied, emphasizing handling the capsule intact for use.*

FDA Label Image

Instructions For Use Figure U (Image 26)

An instructional illustration labeled 'Figure U' showing a capsule with powder inside, accompanied by cautionary text stating 'Capsule not pierced' and indicating the capsule has no piercing holes.*

FDA Label Image

Instructions For Use Figure V (Image 27)

An instructional diagram showing that one dose of TOBI Podhaler capsules equals four capsules. The image depicts four capsule icons side by side, labeled as '1 dose ='. This visual aids in understanding the dosing quantity for the 28 mg Tobramycin capsules.*

FDA Label Image

Instructions For Use Figure W (Image 28)

An instructional diagram labeled Figure W showing a close-up of a respiratory inhaler device with a cap being removed or placed on the mouthpiece section.*

FDA Label Image

Instructions For Use Figure X (Image 29)

An instructional illustration depicting the assembly of the TOBI Podhaler inhalation device and capsule. It shows a hand inserting or loading a capsule into the device mouthpiece, indicating proper positioning for use with the TOBI Podhaler capsule 28 mg inhalation dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.